These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 8734163

  • 1. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Slade AK, Camm AJ.
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():37-49. PubMed ID: 8734163
    [Abstract] [Full Text] [Related]

  • 2. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [Abstract] [Full Text] [Related]

  • 3. [Arrhythmias in cardiomyopathies].
    Kaneko Y, Kurabayashi M.
    Nihon Rinsho; 2002 Jul; 60(7):1434-9. PubMed ID: 12136626
    [Abstract] [Full Text] [Related]

  • 4. Sudden cardiac death.
    Sra J.
    Indian Heart J; 1999 Jul; 51(2):137-59. PubMed ID: 10407542
    [No Abstract] [Full Text] [Related]

  • 5. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ.
    Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract] [Full Text] [Related]

  • 6. Sudden death due to cardiac arrhythmias.
    Huikuri HV, Castellanos A, Myerburg RJ.
    N Engl J Med; 2001 Nov 15; 345(20):1473-82. PubMed ID: 11794197
    [No Abstract] [Full Text] [Related]

  • 7. [Sudden death in hypertrophic myocardiopathy].
    Cardim N, Longo S, Gouveia D, Lousada N, Ferreira T, Pereira AT, Correia JM.
    Rev Port Cardiol; 1995 Sep 15; 14(9):655-9. PubMed ID: 7576766
    [Abstract] [Full Text] [Related]

  • 8. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.
    Rev Port Cardiol; 2005 Mar 15; 24(3):407-15. PubMed ID: 15929624
    [Abstract] [Full Text] [Related]

  • 9. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE.
    Z Kardiol; 2000 Mar 15; 89 Suppl 3():194-205. PubMed ID: 10810803
    [Abstract] [Full Text] [Related]

  • 10. Device therapy in hypertrophic cardiomyopathy.
    Beadle R, Williams L.
    Expert Rev Cardiovasc Ther; 2010 Dec 15; 8(12):1767-75. PubMed ID: 21108558
    [Abstract] [Full Text] [Related]

  • 11. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G, Elliott PM, Pacileo G, Sarubbi B, Thaman R, Calabrò P, Vergara P, Iacomino M, Russo MG, Calabrò R.
    J Cardiovasc Med (Hagerstown); 2006 Sep 15; 7(9):711-3. PubMed ID: 16932087
    [Abstract] [Full Text] [Related]

  • 12. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
    Ostman-Smith I.
    Fundam Clin Pharmacol; 2010 Oct 15; 24(5):637-52. PubMed ID: 20727015
    [Abstract] [Full Text] [Related]

  • 13. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy.
    Chauhan VS, Selvaraj RJ.
    Curr Opin Cardiol; 2007 Jan 15; 22(1):25-32. PubMed ID: 17143041
    [Abstract] [Full Text] [Related]

  • 14. Sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ, Fananapazir L.
    Circulation; 1992 Jan 15; 85(1 Suppl):I57-63. PubMed ID: 1728506
    [Abstract] [Full Text] [Related]

  • 15. The arrhythmogenic substrate--diagnostic and therapeutic implications: hypertrophic cardiomyopathy.
    Slade AK, Saumarez RC, McKenna WJ.
    Eur Heart J; 1993 Sep 15; 14 Suppl E():84-90. PubMed ID: 8223761
    [Abstract] [Full Text] [Related]

  • 16. [Therapy and risk-stratification in hypertrophic cardiomyopathy--a current survey].
    Reith S, Klues HG.
    Z Kardiol; 2003 Apr 15; 92(4):283-93. PubMed ID: 12707787
    [Abstract] [Full Text] [Related]

  • 17. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S, Spirito P, Masi AS, Chiribiri A, Bonamini R, Conte MR.
    Circ Cardiovasc Imaging; 2009 Jul 15; 2(4):349-50. PubMed ID: 19808616
    [No Abstract] [Full Text] [Related]

  • 18. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E, Mangiavacchi M, Andreuzzi B, Municinò A.
    Ital Heart J Suppl; 2001 Dec 15; 2(12):1278-83. PubMed ID: 11838348
    [Abstract] [Full Text] [Related]

  • 19. [Therapy of hypertrophic cardiomyopathy].
    Cecchi F, Olivotto I.
    G Ital Cardiol; 1999 Oct 15; 29(10):1199-203. PubMed ID: 10546134
    [No Abstract] [Full Text] [Related]

  • 20. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.
    Adabag AS, Maron BJ.
    Ann Noninvasive Electrocardiol; 2007 Apr 15; 12(2):171-80. PubMed ID: 17593187
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.